
There Are Two New Drugs to Treat Gonorrhea
The FDA approved two new drugs to treat gonorrhea The new drugs—gepotidacin and zoliflodacin—are both new kinds of antibiotics and represent the first completely new treatment options in over thirty years.
Mgen: The STI You’ve (Probably) Never Heard of
It has been associated with urethritis in men and linked to cervicitis and pelvic inflammatory disease (PID) in women. In one study of young men and women, it was found to be more common than gonorrhea infection. But odds are you’ve never been tested for, or even heard of, this sexually transmitted bacterial infection.
Mycoplasma genitalium, or Mgen, was first identified in 1981. It is a bacterium that can infect the reproductive tract and is passed on through sexual contact. In men, infection with Mgen can cause urethritis (swelling and irritation of the urethra), and in women it has been linked to cervicitis (inflammation of the cervix), PID, and possibly infertility.
While there aren’t statistics to show how common infection with Mgen is, in one study of 2,932 young men and women, Mgen was more prevalent that gonorrhea, but less than chlamydia and trichomoniasis. Like those infections, Mgen can be asymptomatic, particularly in women. Women may have pain with urination, vaginal discharge, or discomfort with sex, while men may experience burning, painful urination and sometimes a discharge from the penis.
There are currently two FDA-approved diagnostic tests for Mgen. Labs can use a specific type of test method—nucleic acid amplification testing (NAAT)—to identify an Mgen infection. Testing can be done on urine, cervical swabs, or urethral swabs.
Since Mgen is a bacterial infection, it can typically be cured with antibiotics, sometimes with a single dose. Occasionally, if a first course of antibiotics doesn’t cure the infection, an additional antibiotic treatment may be required.

The FDA approved two new drugs to treat gonorrhea The new drugs—gepotidacin and zoliflodacin—are both new kinds of antibiotics and represent the first completely new treatment options in over thirty years.

The American Cancer Society (ACS) released new recommendations for cervical cancer screening that focus on HPV testing and approve the use of self-collected samples. The recommendations also clarify the age at which screening should start and stop.

Public health officials in England announced that they have identified a new combined type of mpox. Tests show the virus was a unique mix of the two known types of mpox and experts are concerned about what this means for future spread of the virus.

A committee that advises the Centers for Disease Control and Prevention (CDC) made an alarming change to the recommendations for the hepatitis B vaccine that will leave some infants unprotected.

The Centers for Disease Control and Prevention (CDC) recently made striking changes to its online information about the connection between vaccines and autism that put the agency on the wrong side of science.

A new report from the World Health Organization (WHO) warns of rising levels of drug-resistant gonorrhea. The data comes from reported cases of gonorrhea in 12 countries across five WHO regions.

We’ve known for years that the HPV vaccine works. Now new research shows that widespread vaccination even protects those who haven’t gotten the shot. This study proves that it is possible to reach herd immunity for HPV.

A more serious type of mpox may be spreading California. Three people in the state were hospitalized with the virus.
ASHA believes that all people have the right to the information and services that will help them to have optimum sexual health. We envision a time when stigma is no longer associated with sexual health and our nation is united in its belief that sexuality is a normal, healthy, and positive aspect of human life.
ABOUT
GET INVOLVED
ASHA WEBSITES
GET HELP
© 2025 American Sexual Health Association